TIA1 antibody
Principal name
TIA1 antibody
Alternative names for TIA1 antibody
Nucleolysin TIA-1, p40-TIA-1, p15-TIA-1, RNA-binding protein TIA-1, TIA1 cytotoxic granule-associated RNA binding protein
Ncbi ID
9606, NP_071320, NP_071505, NP_000526, NP_071320.2, NM_022173, BC023813, NM_001164078, NM_011585, NM_001164079, NM_022037
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunoprecipitation (IP), Paraffin Sections (P), Frozen Sections (C)
Background of TIA1 antibody
TIA1 is a member of an RNA binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. It has been suggested that this protein may be involved in the induction of apoptosis as it preferentially recognizes poly(A) homopolymers and induces DNA fragmentation in CTL targets. The major granule-associated species is a 15-kDa protein that is thought to be derived from the carboxyl terminus of the 40-kDa product by proteolytic processing.
TIA-1 (T-cell intracytoplasmic antigen) monoclonal antibody reacts with a 15 kDa cytoplasmic granule-associated protein, expressed in lymphocytes processing cytolytic potential. The expression of TIA-1 was studied in CD30+ anaplastic large cell lymphomas (ALCL), NK cell lymphomas and peripheral T-cell lymphomas and T cell lymphocytosis, B-cell lymphomas and lymphoblastic leukemia, Hodgkin’s etc. Studies showed that 60 to 70% of anaplastic large cell lymphoma reacted with TIA-1. Studies also indicate that TIA-1 reacts with most large granular lymphocytic leukemia's, hepatosplenic T-cell lymphomas, intestinal T-cell lymphomas, NK-like T-cell lymphomas, NK-cell lymphomas, nasal T/NK-cell lymphomas, subcutaneous T-cell lymphomas, pulmonary angiocentric lymphomas of T or NK phenotype. The author's concluded from TIA-1 studies that anaplastic large-cell lymphomas are cytotoxic T-or NK-cell neoplasms. All B-cell lymphomas, Hodgkin's and lymphoblastic leukemias were negative for TIA-1.
General readings
Yang F, Peng Y, Murray EL, Otsuka Y, Kedersha N, Schoenberg DR.
Polysome-bound endonuclease PMR1 is targeted to stress granules via stress-specific binding to TIA-1.
Mol Cell Biol. 2006 Dec;26(23):8803-13. Epub 2006 Sep 18.
PMID: 16982678

























- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA800657 | TIA1 antibody |
||||||
| TIA1 mouse monoclonal antibody, clone OTI1D7 (formerly 1D7) | |||||||
![]() |
Mouse | IgG2b | OTI1D7 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+7 additional images |
Highly validated antibody! |
||||||
| TA303222 | TIA1 antibody |
||||||
| Goat Polyclonal Antibody against TIA1 | |||||||
![]() |
Goat | Aff - Purified | Can, Hu, Ms, Rt | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA800634 | TIA1 antibody |
||||||
| TIA1 mouse monoclonal antibody, clone OTI2B1 (formerly 2B1) | |||||||
![]() |
Mouse | IgG1 | OTI2B1 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA800656 | TIA1 antibody |
||||||
| TIA1 mouse monoclonal antibody, clone OTI1A3 (formerly 1A3) | |||||||
![]() |
Mouse | IgG1 | OTI1A3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA800658 | TIA1 antibody |
||||||
| TIA1 mouse monoclonal antibody, clone OTIC3 (formerly C3) | |||||||
![]() |
Mouse | IgG2b | OTIC3 | Purified | Hu | WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA800659 | TIA1 antibody |
||||||
| TIA1 mouse monoclonal antibody, clone OTI1C8 (formerly 1C8) | |||||||
![]() |
Mouse | IgG1 | OTI1C8 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA800667 | TIA1 antibody |
||||||
| TIA1 mouse monoclonal antibody, clone OTI1C4 (formerly 1C4) | |||||||
![]() |
Mouse | IgG1 | OTI1C4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| AP23048PU-N | TIA1 (189-199) antibody |
||||||
![]() |
Goat | Aff - Purified | Bov, Bt, Can, Chk, Elephant, Hu, Mky, Ms, Rb, Rt, Xen | E, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| BM2703 | TIA1 antibody |
||||||
![]() |
Mouse | IgG1 | 2G9A10F5 | Purified | Hu | C, P |
1 ml /
€450.00
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP319386 | TIA1 (transcript variant 2) |
||||
| Recombinant protein of human TIA1 cytotoxic granule-associated RNA binding protein (TIA1), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY411728 | TIA1 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR203884L2V | Lenti ORF particles, Tia1 (GFP-tagged) - Mouse cytotoxic granule-associated RNA binding protein 1 (cDNA clone MGC:36034 IMAGE:5353938), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR205879L2V | Lenti ORF particles, Tia1 (GFP-tagged) - Mouse cytotoxic granule-associated RNA binding protein 1 (Tia1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR203884L1V | Lenti ORF particles, Tia1 (Myc-DDK-tagged) - Mouse cytotoxic granule-associated RNA binding protein 1 (cDNA clone MGC:36034 IMAGE:5353938), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| MR205879L1V | Lenti ORF particles, Tia1 (Myc-DDK-tagged) - Mouse cytotoxic granule-associated RNA binding protein 1 (Tia1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||






+7 additional images









